Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04225507 · ClinicalTrials.gov registry record · NA

Technology-Supported Treatment of Sleep Apnea in Prediabetes

A NA study of PreDiabetes and Sleep Apnea, sponsored by University of Chicago.

Active
Registry status
NA
Development phase
174
Enrollment target
1
Study location

NCT04225507: Active NA study of PreDiabetes and Sleep Apnea, sponsored by University of Chicago.

NCT04225507 is a NA study of PreDiabetes and Sleep Apnea that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 174 participants, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04225507, a NA study of PreDiabetes and Sleep Apnea, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
174 participants
Enrollment target
1
Study location

Study Summary

Despite the efficacy of intensive lifestyle interventions in prediabetes, the incidence of diabetes is rising, and thus there is a critical need for additional strategies to prevent diabetes and to reduce its cardiovascular complications in this high-risk population. Sleep apnea is a highly common condition in prediabetes, but it has been mostly ignored and undertreated in current practice. The proposed study will be the first to assess whether adding CPAP (continuous positive air pressure) treatment to a lifestyle intervention improves cardiometabolic outcomes beyond that achieved with lifestyle alone (i.e. current standard of care) in high-risk individuals with prediabetes.

Primary Outcome

Glucose levels will be measured at time=120min during oral glucose tolerance test

Interventions

  • BEHAVIORAL Diet and exercise coaching
  • OTHER CPAP Treatment

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2021-04-13
Est. Completion 2026-07
Phase NA
University of Chicago

796 total trials

What the registry record for NCT04225507 still lists

NCT04225507 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (75% lower).

The record links to 3 conditions, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which Diet and exercise coaching is the first listed.

NCT04225507 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04225507 about?

NCT04225507 is a clinical study titled "Technology-Supported Treatment of Sleep Apnea in Prediabetes". Despite the efficacy of intensive lifestyle interventions in prediabetes, the incidence of diabetes is rising, and thus there is a critical need for additional strategies to prevent diabetes and to reduce its cardiovascular complications in this high-risk population. Sleep apnea is a highly common c...

What is the current status of trial NCT04225507?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 174 participants. The study started on 2021-04-13. Estimated completion is 2026-07.

What conditions does trial NCT04225507 study?

This clinical trial studies the following conditions: PreDiabetes, Sleep Apnea, Overweight or Obesity.

What interventions are being tested in trial NCT04225507?

The interventions under investigation include: Diet and exercise coaching (BEHAVIORAL), CPAP Treatment (OTHER).

Who is sponsoring clinical trial NCT04225507?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04225507 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04225507's enrollment target sits among peer trials

174 45th of 149 higher than 105 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01000259 · 174 participants

    Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

  • NCT04729114 · 174 participants · Phase 1

    A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • NCT04884035 · 174 participants · Phase 1

    Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

  • NCT05075980 · 174 participants · Phase 2

    Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04225507, the US trial registry maintained by the National Library of Medicine. NCT04225507 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.